塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/09/11 | 6,479 | 6,502 | 6,448 | 6,486 | +23 | +0.4% | 1,012,100 |
2023/09/08 | 6,420 | 6,484 | 6,419 | 6,463 | +44 | +0.7% | 1,596,000 |
2023/09/07 | 6,452 | 6,479 | 6,400 | 6,419 | -33 | -0.5% | 1,081,800 |
2023/09/06 | 6,446 | 6,464 | 6,433 | 6,452 | -12 | -0.2% | 809,000 |
2023/09/05 | 6,429 | 6,464 | 6,411 | 6,464 | +34 | +0.5% | 904,300 |
2023/09/04 | 6,430 | 6,431 | 6,405 | 6,430 | -2 | ±0% | 691,300 |
2023/09/01 | 6,393 | 6,448 | 6,385 | 6,432 | +15 | +0.2% | 833,100 |
2023/08/31 | 6,463 | 6,472 | 6,393 | 6,417 | -74 | -1.1% | 1,890,100 |
2023/08/30 | 6,476 | 6,521 | 6,470 | 6,491 | +14 | +0.2% | 1,023,100 |
2023/08/29 | 6,452 | 6,489 | 6,441 | 6,477 | +53 | +0.8% | 1,089,900 |
2023/08/28 | 6,410 | 6,443 | 6,403 | 6,424 | +66 | +1% | 1,079,700 |
2023/08/25 | 6,323 | 6,372 | 6,307 | 6,358 | +2 | ±0% | 1,089,100 |
2023/08/24 | 6,296 | 6,356 | 6,296 | 6,356 | +28 | +0.4% | 695,200 |
2023/08/23 | 6,324 | 6,355 | 6,310 | 6,328 | -7 | -0.1% | 826,300 |
2023/08/22 | 6,315 | 6,373 | 6,297 | 6,335 | +35 | +0.6% | 1,220,200 |
2023/08/21 | 6,265 | 6,316 | 6,258 | 6,300 | +58 | +0.9% | 859,500 |
2023/08/18 | 6,250 | 6,257 | 6,215 | 6,242 | -14 | -0.2% | 826,500 |
2023/08/17 | 6,272 | 6,286 | 6,240 | 6,256 | -43 | -0.7% | 957,400 |
2023/08/16 | 6,265 | 6,326 | 6,253 | 6,299 | -10 | -0.2% | 1,160,400 |
2023/08/15 | 6,242 | 6,309 | 6,212 | 6,309 | +67 | +1.1% | 984,200 |
2023/08/14 | 6,268 | 6,344 | 6,241 | 6,242 | -13 | -0.2% | 1,317,000 |
2023/08/10 | 6,200 | 6,260 | 6,177 | 6,255 | +55 | +0.9% | 1,536,000 |
2023/08/09 | 6,160 | 6,201 | 6,157 | 6,200 | +47 | +0.8% | 1,187,600 |
2023/08/08 | 6,130 | 6,153 | 6,099 | 6,153 | +51 | +0.8% | 1,012,200 |
2023/08/07 | 6,003 | 6,103 | 5,999 | 6,102 | +88 | +1.5% | 935,800 |
2023/08/04 | 6,003 | 6,028 | 5,986 | 6,014 | -17 | -0.3% | 1,047,100 |
2023/08/03 | 6,099 | 6,121 | 5,993 | 6,031 | -123 | -2% | 1,406,600 |
2023/08/02 | 6,107 | 6,167 | 6,065 | 6,154 | +16 | +0.3% | 2,507,000 |
2023/08/01 | 6,032 | 6,139 | 6,005 | 6,138 | +206 | +3.5% | 3,008,700 |
2023/07/31 | 5,968 | 5,996 | 5,912 | 5,932 | +36 | +0.6% | 1,741,000 |
2023/07/28 | 5,859 | 5,909 | 5,811 | 5,896 | -26 | -0.4% | 1,627,100 |
2023/07/27 | 5,931 | 5,944 | 5,886 | 5,922 | +4 | +0.1% | 791,300 |
2023/07/26 | 5,899 | 5,921 | 5,863 | 5,918 | +38 | +0.6% | 735,700 |
2023/07/25 | 5,949 | 5,949 | 5,871 | 5,880 | -46 | -0.8% | 987,300 |
2023/07/24 | 5,945 | 5,953 | 5,902 | 5,926 | +44 | +0.7% | 666,800 |
2023/07/21 | 5,879 | 5,929 | 5,859 | 5,882 | +40 | +0.7% | 1,133,800 |
2023/07/20 | 5,900 | 5,913 | 5,834 | 5,842 | -52 | -0.9% | 1,078,800 |
2023/07/19 | 5,850 | 5,894 | 5,838 | 5,894 | +74 | +1.3% | 1,238,400 |
2023/07/18 | 5,812 | 5,826 | 5,785 | 5,820 | -26 | -0.4% | 1,168,400 |
2023/07/14 | 5,812 | 5,873 | 5,806 | 5,846 | +31 | +0.5% | 1,291,200 |
2023/07/13 | 5,787 | 5,827 | 5,775 | 5,815 | +12 | +0.2% | 883,400 |
2023/07/12 | 5,772 | 5,824 | 5,735 | 5,803 | +65 | +1.1% | 1,173,300 |
2023/07/11 | 5,810 | 5,828 | 5,718 | 5,738 | -50 | -0.9% | 1,465,700 |
2023/07/10 | 5,822 | 5,882 | 5,778 | 5,788 | -131 | -2.2% | 2,245,800 |
2023/07/07 | 5,886 | 5,945 | 5,842 | 5,919 | -13 | -0.2% | 1,493,600 |
2023/07/06 | 6,020 | 6,029 | 5,915 | 5,932 | -76 | -1.3% | 1,614,600 |
2023/07/05 | 5,996 | 6,027 | 5,991 | 6,008 | +2 | ±0% | 855,300 |
2023/07/04 | 6,039 | 6,040 | 5,992 | 6,006 | -45 | -0.7% | 1,166,600 |
2023/07/03 | 6,127 | 6,127 | 6,050 | 6,051 | -19 | -0.3% | 1,262,800 |
2023/06/30 | 6,110 | 6,129 | 6,044 | 6,070 | -106 | -1.7% | 1,923,700 |
401~
450
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 245,700円 | +5.7% | +3.9% | 2.50% | 12.22倍 | 1.62倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 769,700円 | +2.2% | +10.2% | 1.56% | 14.78倍 | 1.49倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 427,100円 | +1.7% | -2.9% | 3.75% | 28.02倍 | 1.47倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 219,100円 | -3.5% | -11.3% | 2.74% | 20.12倍 | 1.35倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム